Untapped Potentials: Exploring Overlooked Therapies for Type 2 Diabetes


In this episode of MEDcast, the expert panelists examine some underutilized therapies in type 2 diabetes (T2D) and explore their potential as effective treatment choices for many patients.

To watch the video series component of this episode, click here.

0:50 Need for using older diabetes medications

3:30 Quick-release bromocriptine: benefits in T2D and cardiovascular risk

6:15 Efficacy of quick-release bromocriptine

8:10 Quick-release bromocriptine as monotherapy and as an add-on

9:00 Mechanism of quick-release bromocriptine

11:41 Titrating quick-release bromocriptine

15:50 Benefits of pioglitazone

22:30 Positioning older T2D therapies in the current treatment regimen

Related Videos
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Ralph DeFronzo, MD | Credit: UT San Antonio
Timothy Garvey, MD | Credit: University of Alabama at Birmingham
Atul Malhotra, MD | Credit: Kyle Dykes; UC San Diego Health
Alexandra Louise Møller, MS, PhD | Credit: LinkedIn
A panel of 5 experts on Cushing's syndrome
A panel of 5 experts on Cushing's syndrome
Optimizing Diabetes Therapies with New Classifications
Vlado Perkovic, MBBS, PhD | Credit: George Institute of Global Health
Should We Reclassify Diabetes Subtypes?
© 2024 MJH Life Sciences

All rights reserved.